Evidence map›Paper›PMID 37021934›Full record

ArticleBioinformatics (Oxford, England)2023

SpliceAI-10k calculator for the prediction of pseudoexonization, intron retention, and exon deletion.

Daffodil M Canson, Aimee L Davidson, Miguel de la Hoya, Michael T Parsons, Dylan M Glubb, Olga Kondrashova, Amanda B Spurdle

Open access · goldAbstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Cancer genomic profiling predicts pathogenicity ofmedRxiv : the preprint server for health sciences · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Estimation ofGenetics in medicine open · 2025
    Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Daffodil M CansonPopulation Health Program, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia.ORCID 0000-0002-8104-822X
Aimee L DavidsonPopulation Health Program, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia.
Miguel de la HoyaMolecular Oncology Laboratory CIBERONC, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Hospital Clinico San Carlos, 28040 Madrid, Spain.ORCID 0000-0002-8113-1410
Michael T ParsonsPopulation Health Program, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia.
Dylan M GlubbFaculty of Medicine, The University of Queensland, Herston, QLD 4006, Australia.
Olga KondrashovaCancer Research Program, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia.
Amanda B SpurdlePopulation Health Program, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia.
QIMR Berghofer Medical Research Institute · AUThe University of Queensland · AUInstituto de Investigación Sanitaria del Hospital Clínico San Carlos · ES

Funding

Upgrading rigor and efficiency of germline cancer gene variant classification for the 2020sR01CA264971 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Sean Vahram Tavtigian · 2022 to 2026
$2.9M
NCI NIH HHS R01 CA264971NIH HHS R01 CA264971
6 · The paper itself

Abstract

summarySpliceAI is a widely used splicing prediction tool and its most common application relies on the maximum delta score to assign variant impact on splicing. We developed the SpliceAI-10k calculator (SAI-10k-calc) to extend use of this tool to predict: the splicing aberration type including pseudoexonization, intron retention, partial exon deletion, and (multi)exon skipping using a 10 kb analysis window; the size of inserted or deleted sequence; the effect on reading frame; and the altered amino acid sequence. SAI-10k-calc has 95% sensitivity and 96% specificity for predicting variants that impact splicing, computed from a control dataset of 1212 single-nucleotide variants (SNVs) with curated splicing assay results. Notably, it has high performance (≥84% accuracy) for predicting pseudoexon and partial intron retention. The automated amino acid sequence prediction allows for efficient identification of variants that are expected to result in mRNA nonsense-mediated decay or translation of truncated proteins. AVAILABILITY AND IMPLEMENTATION: SAI-10k-calc is implemented in R (https://github.com/adavi4/SAI-10k-calc) and also available as a Microsoft Excel spreadsheet. Users can adjust the default thresholds to suit their target performance values.

Indexed as

RNA SplicingAmino Acid SequenceExonsIntronsRNA, MessengerRNA, Messenger

Identifiers

PMID37021934
PMCPMC10125908
OpenAlexW4362657807

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.